AbCellera Biologics' Grant - III Round

AbCellera Biologics raised a round of funding on March 15, 2017. Investors include Western Economic Diversification Canada.

AbCellera Biologics is a privately held company that provides technologies to biotechnology and pharmaceutical partners with the goal of discovery and development of next-generation monoclonal antibod…

Articles about AbCellera Biologics' Grant - III Round: